Financial Performance - The company's revenue for Q3 2022 reached ¥233,070,519.45, representing a 66.74% increase compared to the same period last year[4] - Net profit attributable to shareholders was ¥66,601,174.03, a significant increase of 1,696.20% year-on-year[4] - The net profit after deducting non-recurring gains and losses was ¥63,509,904.69, up 978.64% from the previous year[4] - Total operating revenue for the third quarter reached CNY 527.72 million, a significant increase of 38.4% compared to CNY 381.34 million in the same period last year[21] - Net profit for the quarter was CNY 66.39 million, a turnaround from a net loss of CNY 4.03 million in the previous year[24] - Earnings per share (EPS) for the quarter was CNY 0.5735, compared to a loss per share of CNY 0.0352 in the same quarter last year[24] Cash Flow and Liquidity - The operating cash flow net amount for the year-to-date period was ¥131,898,539.63, reflecting a remarkable increase of 5,717.78%[10] - The net cash flow from operating activities for the quarter was ¥131,898,539.63, driven by increased product sales[10] - The net cash flow from operating activities for the current period is ¥131,898,539.63, a significant increase from ¥2,267,161.54 in the previous period, reflecting strong operational performance[25] - The total cash and cash equivalents at the end of the period stand at ¥320,929,060.48, down from ¥739,584,919.14 in the previous period, indicating a decrease in liquidity[27] - The cash flow from operating activities totaled ¥571,219,409.40, compared to ¥387,418,472.37 in the previous period, reflecting improved sales performance[25] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,981,530,026.60, a 5.60% increase from the end of the previous year[5] - Total current assets decreased from ¥919,810,557.90 to ¥799,938,210.68, a decline of about 13.0%[18] - Total liabilities rose to CNY 473.44 million, compared to CNY 438.92 million in the previous year, marking an increase of 7.4%[20] - The company's equity attributable to shareholders reached CNY 1.50 billion, an increase from CNY 1.43 billion, representing a growth of 4.5%[20] Shareholder Information - Total number of common shareholders at the end of the reporting period is 11,633[12] - The largest shareholder, Yu Yangchao, holds 30.84% of shares, totaling 35,987,628 shares[12] - The top ten shareholders include Jiangsu Gaotou Development Venture Capital Co., holding 7.40% of shares[12] Research and Development - Research and development expenses increased by 63.42% to ¥10,425,054.33, indicating a focus on innovation[10] - Research and development expenses for the quarter were CNY 10.43 million, up 63.9% from CNY 6.38 million in the previous year, indicating a strong focus on innovation[21] Inventory and Operational Costs - The company reported a significant increase in inventory by 31.04% to ¥141,420,684.26, attributed to business expansion[10] - Operating costs amounted to CNY 473.59 million, up 19.6% from CNY 396.23 million year-on-year[21] - Inventory increased from ¥107,921,860.27 to ¥141,420,684.26, an increase of approximately 30.9%[18] Investment Activities - Total cash inflow from investment activities reached ¥1,507,677,172.56, compared to ¥39,644,265.37 in the previous period, indicating a substantial increase in investment activity[27] - The company reported an investment income of CNY 2.33 million, compared to CNY 0.62 million in the same period last year, reflecting a positive trend in investment performance[21] - The company received cash from the absorption of investments amounting to ¥4,100,000.00, up from ¥500,000.00 in the previous period, reflecting increased investor confidence[27] Other Information - The company has not reported any new product developments or market expansions in the current quarter[13] - There are no indications of mergers or acquisitions in the recent financial disclosures[13] - The company has a total of 48,360,504 restricted shares, all of which are subject to lock-up until April 11, 2024[16]
华绿生物(300970) - 2022 Q3 - 季度财报